Clarity Pharmaceuticals Ltd
CLRPF·OTC Markets OTCPK·Healthcare
1.0000−0.1000 (−9.09%)today
As of Nov 4, 9:30 AM EST · May be delayed up to 15 min · USD
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close1.1000
Open1.0000
Day range—
52-week range1.00003.1500
Off day high0.00%
Off 52-week high−68.25%
Volume51.00K
Avg. volume (3M)11.44K
Market cap373.08M
EPS (TTM)-0.2000
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.18
Shares outstanding373.08M
Short interest—
Earnings dateAug 18, 2025 (est.)
Analyst target—
Profit margin0.00%
Against its peers
Compare in full ›| CLRPF | MNPR | AKTS | 0RC6.IL | ANL | AURA | |
|---|---|---|---|---|---|---|
| Market cap | 373.08M | 488.71M | 827.90M | 1.21B | 580.23M | 659.56M |
| P/E (TTM) | — | — | — | 60.1 | — | — |
| Forward P/E | — | -38.0 | -7.0 | — | -30.6 | -3.1 |
| Price/book | 2.9 | 3.7 | 1.7 | 5.7 | 2.7 | 2.1 |
| Dividend yield | — | — | — | 2.09% | — | — |
| 1-year change | −65.08% | −9.84% | −32.14% | −8.11% | +520.00% | +22.92% |
| Today | −9.09% | +4.18% | −2.07% | +0.72% | −6.24% | −4.36% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All CLRPF news ›Clarity Pharmaceuticals hits target for SECuRE trial cohort
Assets related to this article Clarity Pharmaceuticals (ASX:CU6) completed recruitment for the main group of its Phase 1/2a SECuRE trial evaluating 16 patients with metastatic castration-resistant prostate cancer. The trial aims to assess…
From the 4Search news index, newest first.
In the news
1mentions in 30 days
1with it in the headline
Positivesentiment
Mentioned with
People in the coverage
Most coverage from
- grafa.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.